Literature DB >> 25587138

Uncommon use of common measures in sulforaphane trial.

Lawrence Scahill1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25587138      PMCID： PMC4313799          DOI： 10.1073/pnas.1422266112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Sulforaphane treatment of autism spectrum disorder (ASD).

Authors:  Kanwaljit Singh; Susan L Connors; Eric A Macklin; Kirby D Smith; Jed W Fahey; Paul Talalay; Andrew W Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

2.  Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  2005-11

3.  Validity of the aberrant behavior checklist in children with autism spectrum disorder.

Authors:  Aaron J Kaat; Luc Lecavalier; Michael G Aman
Journal:  J Autism Dev Disord       Date:  2014-05

4.  Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised.

Authors:  John N Constantino; Sandra A Davis; Richard D Todd; Matthew K Schindler; Maggie M Gross; Susan L Brophy; Lisa M Metzger; Christiana S Shoushtari; Reagan Splinter; Wendy Reich
Journal:  J Autism Dev Disord       Date:  2003-08

5.  Risperidone in children with autism and serious behavioral problems.

Authors:  James T McCracken; James McGough; Bhavik Shah; Pegeen Cronin; Daniel Hong; Michael G Aman; L Eugene Arnold; Ronald Lindsay; Patricia Nash; Jill Hollway; Christopher J McDougle; David Posey; Naomi Swiezy; Arlene Kohn; Lawrence Scahill; Andres Martin; Kathleen Koenig; Fred Volkmar; Deirdre Carroll; Allison Lancor; Elaine Tierney; Jaswinder Ghuman; Nilda M Gonzalez; Marco Grados; Benedetto Vitiello; Louise Ritz; Mark Davies; James Robinson; Don McMahon
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245
  5 in total
  3 in total

1.  Reply to Scahill: Behavioral outcome measures in autism.

Authors:  Paul Talalay; Andrew W Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-13       Impact factor: 11.205

Review 2.  Clinician- and Patient-reported Endpoints in CNS Orphan Drug Clinical Trials: ISCTM Position Paper on Best Practices for Endpoint Selection, Validation, Training, and Standardization.

Authors:  Joan Busner; Gahan Pandina; SilviaZaragoza Domingo; Anna-Karin Berger; Maria T Acosta; Nahome Fisseha; Joseph Horrigan; Jelena Ivkovic; William Jacobson; Dennis Revicki; Victoria Villalta-Gil
Journal:  Innov Clin Neurosci       Date:  2021 Oct-Dec

3.  Sulforaphane from Broccoli Reduces Symptoms of Autism: A Follow-up Case Series from a Randomized Double-blind Study.

Authors:  Rhoda Lynch; Eileen L Diggins; Susan L Connors; Andrew W Zimmerman; Kanwaljit Singh; Hua Liu; Paul Talalay; Jed W Fahey
Journal:  Glob Adv Health Med       Date:  2017-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.